Blog
Feedback
schliessen

Filtern

 

Bibliotheken

Logo der Bibliothek

Logo FID Pharmazie PubPharm Discovery System Universitätsbibliothek Braunschweig Institut für Informationssysteme

Opportunistic Fungal Infections in the Epidemic Area of COVID-19 : A Clinical and Diagnostic Perspective from Iran

The coronavirus disease 2019 (COVID-19) pandemic emerged in Wuhan, China, in late 2109, and has rapidly spread around the world. Until May 25, 2020, there were 133,521 confirmed COVID-19 cases and 7359 deaths in Iran. The role of opportunistic fungal infections in the morbidity and mortality of COVID-19 patients remains less defined. Based on our multicenter experiences, we categorized the risks of opportunistic fungal infections in COVID-19 patients in Iran. The COVID-19 patients at high risk included those with acute respiratory distress syndrome, in intensive care units, receiving broad-spectrum antibiotics, immunosuppressants or corticosteroid, and supported by invasive or noninvasive ventilation. The patients were most likely to develop pulmonary aspergillosis, oral candidiasis, or pneumocystis pneumonia. Most diagnoses were probable as the accurate diagnosis of opportunistic fungal infections remains challenging in resource-poor settings. We summarize the clinical signs and laboratory tests needed to confirm candidiasis, aspergillosis, or pneumocystosis in our COVID-19 patients

Year of Publication: 2020
Contained in: Mycopathologia (31.07.2020)
All journal articles: Search for all articles in this journal
Language: English
Contributors: Salehi, Mohammadreza | Author
Ahmadikia, Kazem
Badali, Hamid
Khodavaisy, Sadegh
Full text access:
Electronic availability is being checked...
Links: Full Text (dx.doi.org)
Keywords: COVID-19
Critical patients pneumonia
Fungal infections
Iran
Journal Article
ISSN: 1573-0832
Note: Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Notes: Date Revised 03.08.2020
published: Print-Electronic
Citation Status Publisher
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PMID:
    32737746
Physical Description: Online-Ressource
ID (e.g. DOI, URN): 10.1007/s11046-020-00472-7
more publication details ...

Associated Publications

  • Associated records are being queried...
more (+)
Internes Format
LEADER 02626nma a2200481 c 4500
001 NLM314059083
003 DE-601
005 20200803214425.0
007 cr uuu---uuuuu
008 200801s2020 000 0 eng d
024 7 |a 10.1007/s11046-020-00472-7  |2 doi 
028 5 2 |a pubmed20n1289.xml 
035 |a (DE-599)NLM32737746 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Salehi, Mohammadreza 
245 1 0 |a Opportunistic Fungal Infections in the Epidemic Area of COVID-19  |h Elektronische Ressource  |b A Clinical and Diagnostic Perspective from Iran 
300 |a Online-Ressource 
500 |a Date Revised 03.08.2020 
500 |a published: Print-Electronic 
500 |a Citation Status Publisher 
500 |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine 
520 |a The coronavirus disease 2019 (COVID-19) pandemic emerged in Wuhan, China, in late 2109, and has rapidly spread around the world. Until May 25, 2020, there were 133,521 confirmed COVID-19 cases and 7359 deaths in Iran. The role of opportunistic fungal infections in the morbidity and mortality of COVID-19 patients remains less defined. Based on our multicenter experiences, we categorized the risks of opportunistic fungal infections in COVID-19 patients in Iran. The COVID-19 patients at high risk included those with acute respiratory distress syndrome, in intensive care units, receiving broad-spectrum antibiotics, immunosuppressants or corticosteroid, and supported by invasive or noninvasive ventilation. The patients were most likely to develop pulmonary aspergillosis, oral candidiasis, or pneumocystis pneumonia. Most diagnoses were probable as the accurate diagnosis of opportunistic fungal infections remains challenging in resource-poor settings. We summarize the clinical signs and laboratory tests needed to confirm candidiasis, aspergillosis, or pneumocystosis in our COVID-19 patients 
611 2 7 |a Journal Article  |2 gnd 
655 7 |a COVID-19  |2 gnd 
655 7 |a Critical patients pneumonia  |2 gnd 
655 7 |a Fungal infections  |2 gnd 
655 7 |a Iran  |2 gnd 
689 0 0 |A f  |a Journal Article 
689 0 |5 DE-601 
689 1 0 |a COVID-19 
689 1 1 |a Critical patients pneumonia 
689 1 2 |a Fungal infections 
689 1 3 |a Iran 
689 1 |5 DE-601 
700 1 |a Ahmadikia, Kazem 
700 1 |a Badali, Hamid 
700 1 |a Khodavaisy, Sadegh 
773 0 8 |i in  |t Mycopathologia  |g  (31.07.2020)  |w (DE-601)NLM000021210  |x 1573-0832 
856 4 1 |u http://dx.doi.org/10.1007/s11046-020-00472-7  |3 Volltext 
912 |a GBV_NLM 
951 |a AR 
952 |j 2020  |b 31  |c 07